*Some Market data delayed by 15 mins.

PROCEPT BioRobotics Corporation Common Stock

Symbol: PRCT (NASDAQ)
37.49 ▼ (-0.04%) -0.015

Company Description:
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Key Stats
  • Today's Open: $37.575
  • Today's High: $37.64
  • Today's Low: $37.489
  • Today's Volume: 1.78K
  • Yesterday Close: $37.5
  • Yesterday High: $39.11
  • Yesterday Low: $37.13
  • Yesterday Volume: 1.58M
  • Last Min Volume: 275
  • Last Min High: $37.613
  • Last Min Low: $37.49
  • Last Min VWAP: $37.613
Company Profile
  • Name: PROCEPT BioRobotics Corporation Common Stock
  • Website: https://www.procept-biorobotics.com
  • Listed Date: 2021-09-15
  • Location: SAN JOSE, CA
  • Market Status: Active
  • CIK Number: 0001588978
  • SIC Code: 3841
  • SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Market Cap: $2.09B
  • Round Lot: 100
  • Outstanding Shares: 55.64M
  • Asset Type: CS
RECENT FILINGS FOR PRCT
Filing Date Filing Type Format
2025-09-04 4 View
2025-08-15 4 View
2025-08-14 4 View
2025-08-14 4 View
2025-08-07 10-Q View
2025-08-06 8-K View
2025-07-25 8-K View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-12 4 View
2025-06-11 8-K View
2025-06-06 144 View
2025-06-06 4 View
2025-06-05 4 View
2025-06-03 144 View
Latest News on PRCT

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.